SCHEMBL20402154

SCHEMBL20402154

c1csc(-c2ccc3c(c2)[nH]c2c3ccc3c2ccc2c4ccc(-c5cccs5)cc4sc23)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR17 Q13304 1/20 0.42
PTGES O14684 1/20 0.40
TDO2 P48775 1/20 0.39
KCNH2 Q12809 1/20 0.38
HTR1D P28221 4/20 0.36
HTR1B P28222 4/20 0.36
CDK2 P24941 1/20 0.36
GSK3A P49840 1/20 0.36
GSK3B P49841 1/20 0.36
TUBB4A P04350 2/20 0.35
TUBB P07437 2/20 0.35
TUBA3C P0DPH7 2/20 0.35
TUBA1B P68363 2/20 0.35
TUBA4A P68366 2/20 0.35
TUBB4B P68371 2/20 0.35
TUBB3 Q13509 2/20 0.35
TUBB2A Q13885 2/20 0.35
TUBB8 Q3ZCM7 2/20 0.35
TUBA3E Q6PEY2 2/20 0.35
TUBA1A Q71U36 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20402153 0.82 LIMK1 (0.45) GPR17PTGESTDO2GSK3BCHEK1
SCHEMBL29489772 0.80 GPR17 (0.53) GPR17PTGESKCNH2HTR1DHTR1B
SCHEMBL2239471 0.80 GPR17 (0.53) GPR17PTGESKCNH2HTR1DHTR1B
SCHEMBL18470275 0.78 KCNH2 (0.50) GPR17KCNH2HTR1DHTR1BSLC6A11
SCHEMBL18470267 0.75 LTA4H (0.44) KCNH2ERN1ALK
SCHEMBL20201645 0.75 LIMK1 (0.46) GPR17KCNH2SLC6A11ERN1ALK
SCHEMBL20402268 0.74 PRKDC (0.43) KCNH2HTR1DHTR1BSLC6A11ERN1
SCHEMBL18470290 0.72 KDM4E (0.50) KCNH2ERN1
SCHEMBL29159128 0.72 RAB9A (0.49) KCNH2HTR1DHTR1BSLC6A11ERN1
SCHEMBL31153221 0.72 RAB9A (0.49) KCNH2HTR1DHTR1BSLC6A11ERN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10032993-B2 Aromatic heterocyclic compound, manufacturing method thereof, organic semiconductor material, and organic semiconductor device NIPPON STEEL & SUMIKIN CHEMICAL CO., LTD. (JP) 2018-07-24 US disclosed
US-10032993-B2 Aromatic heterocyclic compound, manufacturing method thereof, organic semiconductor material, and organic semiconductor device NIPPON STEEL & SUMIKIN CHEMICAL CO., LTD. (JP) 2018-07-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10032993-B2 Aromatic heterocyclic compound, manufacturing method thereof, organic semiconductor material, and organic semiconductor device PAH, TYR, SLCO2A1 GPR17 1920/4885PTGES 3010/4885TDO2 26/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.